Additionally, isorhamnetin suppresses NF-κB activity in colon cancer, leading to decreased inflammation and tumor progression, and limits the secretion of MMPs and angiogenesis, further inhibiting invasion and metastasis (Figure 4 and Figure 5). The gene discussed is NFKB1; the disease is neoplasm.